The top analyst upgrades, downgrades and other research calls from Friday include Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal and Stratasys.
The top analyst upgrades, downgrades and other research calls from Tuesday include Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix and UnitedHealth.
The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
Thursday was a strong day for the U.S. markets with all major exchanges hitting record all-time highs. Crude oil finally fought back and pushed back over $50, but it still could close…
The September 15 short interest data have been compared with the previous report, and short interest in all the selected biotech stocks increased.
A new Jefferies research report features a new list of top growth stocks to buy, and the list is dominated by top technology and biotechnology companies.
The August 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
Celgene received an update from the FDA early on Thursday. Although shares did not dip initially, this action could prove to be problematic for the biotech giant going forward.
Chris Lange The August 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The top analyst upgrades, downgrades and other research calls from Monday include American Airlines, Celgene, Citigroup, Facebook, Hertz, Hilton and Ulta Beauty.
The July 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The June 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has grown, and…
